Sarah Carmody | Executive Director, Investor Relations and Corporate Communications |
Anna Protopapas | President, CEO & Director |
Dirk Huebner | Chief Medical Officer |
Timothy Lowinger | Chief Scientific Officer |
Brian DeSchuytner | SVP, Finance & Product Strategy |
Boris Peaker | Cowen and Company |
John Barrett | SVB Leerink |
Earl DeSouza | H.C. Wainwright & Co. |
Jessica Fye | JPMorgan Chase & Co. |
Good morning, and welcome to Mersana Therapeutics Second Quarter 2019 Conference Call. [Operator Instructions].
I would now like to turn the call over to Sarah Carmody, Executive Director, Investor Relations and Corporate Communications. Please proceed.
Good morning.